Within the 14 gout patients, less crystal deposition was seen in the subgroup of 8 patients on therapy. None of the asymptomatic hyperuricemia patients were being treated, but it would seem plausible that therapy would reduce the risk of deposits based on data observed in the gout group.
Dr. Samuels said he has no disclosures.